IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2566 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1The clinical challenges of akathisia
James B. Lohr,Carolyn A. Eidt,Areej Abdulrazzaq Alfaraj,Mounir A. Soliman
CNS Spectrums.2015;20(S1)1
[DOI]
2Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment
Shaina Musco,Vivian McAllister,Ian Caudle
Therapeutic Advances in Psychopharmacology.2020;10(S1)204512532093757
[DOI]
3Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment
P. Chue,J. Chue
Therapeutic Advances in Psychopharmacology.2016;38(S1)35
[DOI]
4Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report
Masahiro Takeshima,Hiroyasu Ishikawa,Yuka Kikuchi,Takashi Kanbayashi,Tetsuo Shimizu
Clinical Psychopharmacology and Neuroscience.2018;16(3)346
[DOI]
5The Role of Antypsychotic Therapy in the Development of Akathisia in Patients with Schizophrenia
A. A. Goncharova,E. G. Kornetova
Psychiatry.2020;18(2)32
[DOI]
6Clozapine
A. A. Goncharova,E. G. Kornetova
Reactions Weekly.2016;1588(1)84
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow